Stanley-Laman Group’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,351
Closed -$992K 299
2019
Q4
$992K Buy
11,351
+126
+1% +$11K 0.23% 146
2019
Q3
$952K Buy
11,225
+16
+0.1% +$1.43K 0.24% 135
2019
Q2
$1.18M Sell
11,209
-40
-0.4% -$4.02K 0.28% 108
2019
Q1
$1.19M Buy
11,249
+1
+0% +$100 0.29% 103
2018
Q4
$941K Buy
+11,248
New +$1.02M 0.26% 117

Other funds holding NGVT

Stanley-Laman Group's NGVT Position: Q1 2020 in Review

Stanley-Laman Group sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 11,351 shares — an estimated $992K sold.

Stanley-Laman Group first reported a position in NGVT in Q4 2018 and held it in 5 quarters. The position peaked at $1.19M in Q1 2019. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • Stanley-Laman Group reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • Stanley-Laman Group sold 11,351 Ingevity shares in Q1 2020, an estimated $992K.
  • Stanley-Laman Group first reported a position in Ingevity in Q4 2018 and held it in 5 quarters.
  • Stanley-Laman Group's Ingevity position peaked at $1.19M in Q1 2019.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Stanley-Laman Group's 13F filing for Q1 2020, filed 12 May 2020.